Do HMG-CoA reductase inhibitors improve kidney function? The saga continues

被引：9
|
作者：
Campese, Vito M. [1 ]
Ku, Elaine [1 ]
Bigazzi, Roberto [1 ]
Bianchi, Stefano [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Div Nephrol, Los Angeles, CA 90033 USA
来源：
JOURNAL OF NEPHROLOGY | 2011年 / 24卷 / 05期
关键词：
Chronic kidney disease; Proteinuria; Statins; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; RENAL-FUNCTION; ROSUVASTATIN; ATORVASTATIN; PROGRESSION; DYSLIPIDEMIA; EFFICACY; STATINS; WOMEN;
D O I：
10.5301/jn.5000024
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Several reviews have addressed the role of dyslipidemia in renal injury and the potential renal protective effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins). Experimental evidence in animals strongly supports the concept that statins may be renal protective. However, data in humans are scanty and contradictory. A recent controlled study using rosuvastatin has cast some doubts on the renal protective effect of this drug. This article reviews the available evidence pro and con the renal protective effects of statins in human subjects.
引用
收藏
页码：550 / 553
页数：4
相关论文
共 50 条
  • [1] HMG-CoA reductase inhibitors and the kidney
    Campese, V. M.
    Park, J.
    KIDNEY INTERNATIONAL, 2007, 71 (12) : 1215 - 1222
  • [2] HMG-CoA reductase inhibitors and the kidney
    Vito M. Campese
    Bassel Hadaya
    Josephine Chiu
    Current Hypertension Reports, 2005, 7 : 337 - 342
  • [3] Comparing HMG-CoA reductase inhibitors
    Jones, PH
    CLINICAL CARDIOLOGY, 2003, 26 (01) : I15 - I20
  • [4] HMG-CoA Reductase Inhibitors in Chronic Kidney Disease
    A. Olyaei
    J. L. Steffl
    J. MacLaughlan
    M. Trabolsi
    S. P. Quadri
    I. Abbasi
    E. Lerma
    American Journal of Cardiovascular Drugs, 2013, 13 : 385 - 398
  • [5] Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease
    Fried, Linda F.
    KIDNEY INTERNATIONAL, 2008, 74 (05) : 571 - 576
  • [6] Rhabdomyolysis and HMG-CoA reductase inhibitors
    Omar, MA
    Wilson, JP
    Cox, TS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1096 - 1107
  • [7] HMG-CoA Reductase Inhibitors in Chronic Kidney Disease
    Olyaei, A.
    Steffl, J. L.
    MacLaughlan, J.
    Trabolsi, M.
    Quadri, S. P.
    Abbasi, I.
    Lerma, E.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (06) : 385 - 398
  • [8] Do HMG-CoA reductase inhibitors affect fibrinogen?
    Song, JC
    White, CM
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 236 - 241
  • [9] Pitavastatin: The Newest HMG-CoA Reductase Inhibitor
    Watson, Karol E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2010, 11 (01) : 28 - 34
  • [10] Inhibitors of HMG-CoA Reductase: Current and Future Prospects
    Singh, Narender
    Tamariz, Joaquin
    Chamorro, German
    Medina-Franco, Jose L.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (11) : 1272 - 1283
12345